The Effects of Thrombopoietin on the Growth of Acute Myeloblastic Leukemia Cells

References

• Sauvage F. J., Hass P. E., Spencer S. D., Malloy B. E., Gurney A. L., Spencer S. A., Darbonne W. C., Henzel W. J., Wong S. C., Kuang W., Oles K. J., Hultgen B., Sonberg L. A., Goed-Del D. V., Eaton D. L. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-mpl ligand. Nature 1994; 369: 533–538
   PubMed Web of Science ®Google Scholar
• Lok S., Kaushansky K., Holly R. D., Kuijper J. L., Loton-Day C. E., Oort P. J., Grant F. J., Heipel M. D., Burkhead S. K., Kramer J. M., Bell L. A., Sprecher C. A., Blumberg H., Johnson R., Prunkard D., Ching A. F. T., Mathewes S. L., Bailey M. C., Forstrom J. W., Buddle M. M., Osborn S. G., Evans S. J., Sheppard P. O., Presnell S. R., O'Hara P. J., Hagen F. S., Roth G. J., Foster D. C. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production. in vivo. Nature 1994; 369, 565–568
   Web of Science ®Google Scholar
• Kaushansky K., Lok S., Holly R. D., Broudy V. C., Lin N., Bailey M. C., Forstrom J. W., Buddle M. M., Oort P. J., Hagen F. S., Roth G. J., Papayannopoulou T., Foster D. C. Promotion of megakaryocyte progenitor expansion and differentiation by the c-mpl ligand thrombopoietin. Nature 1994; 369: 568–571
   PubMed Web of Science ®Google Scholar
• Wendling F., Maraskovsky E., Devili N., Florindo C., Teepe M., Titeux M., Methia N., Breton-Gorius J., Cosman D., Vainchenker W. c-mpl ligand is a humoral regulator of megakaryocytopoiesis. Nature 1994; 369: 571–574
   PubMed Web of Science ®Google Scholar
• Bartley T. D., Bogenberger J., Hunt P., Li Y. S., Lu H. S., Martin F., Chang M. S., Samel B., Nichol J. L., Swift S., Johonson M. J., Hsu R. Y., Parker V. P., Suggs S., Skrine J. D., Merewether L. A., Clogston C., Hsu E., Hokom M. M., Choi E., Pangelinan M., Sun Y., Mar V., McNinch M. J., Simonet L., Jacobsen F., Xie C., Shutter J., Chute H., Basu R., Selander L., Trollinger D., Sleu L., Padilla D., Trail G., Elliott G., Izumi R., Covey T., Crouse J., Garcia A., Xu W., Castillo J. D., Biron J., Cole S., Hu M. C. T., Pacifici R., Ponting I., Saris C., Wen D., Yung Y. P., Lin H., Bosselman R. A. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor. mpl. Cell 1994; 77, 1117–1124
   Google Scholar
• Kato T., Ogami K., Shimada Y., Iwamatsu A., Sohma Y., Akahori H., Horie K., Kokubo A., Kudo Y., Maeda E., Kobayashi K., Ohashi H., Ozawa T., Inoue H., Kawamura K., Miyazaki H. Purification and characterization of human thrombopoietin. J. Biochem. 1995; 118: 229–236
   PubMed Web of Science ®Google Scholar
• Kuter D. J., Beeler D. L., Rosenberg R. D. The purification of megapoietin: A phisiological regulator of megakaryocyte growth and platelet production. Proc. Natl. Acad. Sci. USA 1994; 91: 11104–11108
   PubMed Web of Science ®Google Scholar
• Wendling F., Varlet P., Charon M., Tambourin P. MPLV: A retrovirus complex inducing an acute myeloproliferative leukemic disorder in adult mice. Virology 1986; 149: 242–246
   PubMed Web of Science ®Google Scholar
• Souyri M., Vigon I., Penciolelli J. F., Heard J. M., Tambourin P., Wendling F. A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors. Cell 1990; 63: 1137–1147
   PubMed Web of Science ®Google Scholar
• Vigon I., Mornon J. P., Cocault L., Mitjavila M. T., Tambourin P., Gisselbrecht S., Souyri M. Molecular cloning and characterization of MPL, the human homolog of v-mpl oncogene: Identification of a member of the hematopoietic growth factor receptor superfamily. Proc. Natl. Acad. Sci. USA 1992; 89: 5640–5644
   PubMed Web of Science ®Google Scholar
• Skoda R. C., Seldin D. C., Chiang M., Peichel C. L., Vogt T. F., Leder P. Murine c-mpl: a member of the hematopoietic growth factor receptor superfamily that transduces a proliferative signal. EMBO J. 1993; 12: 2645–2653
   PubMed Web of Science ®Google Scholar
• Methia N., Louache F., Vainchenker W., Wendling F. Oligodeoxynucleotides antisense to the c-mpl specifically inhibit in vitro megakatyocytopoiesis. Blood 1993; 82: 1395–1401
   PubMed Web of Science ®Google Scholar
• Zeigler F. C., Sauvage F., Widmer H. R., Keller G. A., Donahue C., Schreiber R. D., Malloy B., Hass P., Eaton D., Matthews W. In vitro megakaryocytopoietic and thrombopoietic activity of c-mpl ligand (TPO) on purified murine hematopoietic stem cells. Blood 1994; 84: 4045–4052
   PubMed Web of Science ®Google Scholar
• Kaushansky K., Broudy V. C., Lin N., Jorgensen M. J., McCarty J., Fox N., Zucker-Franklin D., Lofton-Day C. Thrombopoietin. the mpl ligand is essential for full megakaryocyte development. Proc. Natl. Acad. Sci. USA 1995; 92: 3234–3238
   PubMed Web of Science ®Google Scholar
• Broudy V. C., Lin N. L., Kaushansky K. Thrombopoietin (c-mpl ligand) acts synergistically with erthropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increase megakaryocyte ploidy in vitro. Blood 1995; 85: 1719–1726
   PubMed Web of Science ®Google Scholar
• Banu N., Wang J., Deng B., Groopman J. E., Avraham H. Modulation of megakaryocytopoiesis by thrombopoietin: the c-mpl ligand. Blood 1995; 86: 1331–1338
   PubMed Web of Science ®Google Scholar
• Gurney A. L., Carver-Moore K., Sauvage F. J., Moore M. W. Thrombocytopenia in c-mpl-deficient mice. Science 1994; 265: 1445–1447
   PubMed Web of Science ®Google Scholar
• Sauvage F. J., Luoh S. M., Carver-Moore K., Ryan A., Dowd M., Eaton D. L., Moore M. W. Deficiencies in early and late stages of megakaryocytopoiesis in TPO-KO mice. Blood 1995; 86, 255a (abstr. suppl. 1)
   PubMed Web of Science ®Google Scholar
• Ikeda H., Kanakura Y., Tamaki T., Kuriu A., Kitayama H., Ishikawa J., Kanayama Y., Yonazawa T., Tarui S., Griffin J. D. Expression and functional role of the proto-oncogene c-kit in acute myeloblastic leukemia cells. Blood 1991; 78: 2962–2968
   PubMed Web of Science ®Google Scholar
• Park L. S., Waldron P. E., Friend D., Sassenfeld H. M., Price V., Anderson D., Cosman D., Andrews R. G., Bernstein I. D., Urdal D. L. Interleukin-3, GM-CSF, and G-CSF receptor expression on cell lines and primary leukemia cells: Receptor heterogeneity and relationship to growth factor responsiveness. Blood 1989; 74: 56–65
   PubMed Web of Science ®Google Scholar
• Broudy V. C., Smith F. O., Lin N., Egrie J., Bernstein I. D. Blasts from patients with acute myelogenous leukemia express functional receptors for stem cell factor. Blood 1992; 80: 60–67
   PubMed Web of Science ®Google Scholar
• Begley C. G., Metcalf D., Nicola N. A. Primary human myeloid leukemia cells: Comparative Responsiveness to proliferative stimulation by GM-CSF or G-CSF and membrane expression of CSF receptors. Leukemia 1987; 1: 1–8
   PubMed Web of Science ®Google Scholar
• Budel L. M., Touw I. P., Delwel R., Clark S. C., Lowenberg B. Interleukin-3 and granulocyte-monocyte colony-stimulating factors on human acute myelocytic leukemia cells and relationship to the proliferative response. Blood 1989; 74: 565–571
   PubMed Web of Science ®Google Scholar
• Dubreuil P., Torres H., Courcoul M. A., Birg F., Mannoni P. c-fms expression is a molecular marker of human acute myeloid leukemias. Blood 1988; 72: 1081–1085
   PubMed Web of Science ®Google Scholar
• Griffin J. D., Young D., Hermann F., Wiper D., Wagner K., Sabbath K. D. Effects of recombinant GM-CSF on proliferation of clonogenic cells of acute myeloid leukemia. Blood 1986; 67: 1448–1453
   PubMed Web of Science ®Google Scholar
• Matsumura I., Kanakura Y., Kato T., Ikeda H., Ishikawa J., Horikawa Y., Hashimoto K., Moriyama Y., Tsujimura T., Nishiura T., Miyazaki H., Matsuzawa Y. Growth response of acute myeloblastic leukemia cells to recombinant human thrombopoietin. Blood 1995; 86: 703–709
   PubMed Web of Science ®Google Scholar
• Debili N., Wendling F., Cosman D., Titeux M., Florindo C., Dusanter-Fourt I., Schooley K., Methia N., Charon M., Nador R., Battaieb A., Vainchenker W. The mpl receptor is expressed in the megakaryocytic lineage from late progenitor to platelets. Blood 1995; 85: 391–401
   PubMed Web of Science ®Google Scholar
• Vigon I., Dreyfus F., Melle J., Viguie F., Ribrag V., Cocault L., Souyri M., Gisselbrecht S. Expression of the c-mpl proto-oncogene in human hematologic malignancies. Blood 1993; 82: 877–883
   PubMed Web of Science ®Google Scholar
• Bouscary D., Preudhomme C., Ribrag V., Mell J., Viguie F., Picard F., Guensu M., Fenaux P., Gisselbrecht S., Dreyfus F. Prognostic value of c-mpl expression in myelodysplastic syndromes. Leukemia 1995; 9: 783–788
   PubMed Web of Science ®Google Scholar
• Kanakura Y., Sugahara H., Mitsui H., Ikeda H., Furitsu T., Yagura H., Kitayama H., Kanayama Y., Matsuzawa Y. Functional expression of interleukin 2 receptor in a human factor-dependent megakaryoblastic leukemia cell line: Evidence that granulocyte-macrophage colony-stimulating factor inhibits interleukin 2 binding to its receptor. Cancer Res. 1993; 53: 675–680
   PubMed Web of Science ®Google Scholar
• Kitamura T., Tange T., Terasawa T., Chiba S., Kuwaki T., Miyagawa K., Piao Y. F., Miyazono K., Urabe A., Takaku F. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J. Cell Physiol. 1989; 140: 323–334
   PubMed Web of Science ®Google Scholar
• Matsumura I., Kanakura Y., Ikeda H., Ishikawa J., Kitayama H., Tahara T., Kato T., Miyazaki H., Matsuzawa Y. Blood 1995; 86, 20a. (abstr. suppl. 1)
   PubMedGoogle Scholar
• Piacibello W., Sanavio F., Garetto L., Severino A., Fubini L., Stacchini A., Dragonetti G., Aglietta M. Blood 1995; 86, 45a. (abstr. suppl. 1)
   PubMedGoogle Scholar
• Hirai H., Shimazaki C., Goto H., Inaba T., Sumikuma T., Kikuta T., Sudo Y., Yamagata N., Ashihara E., Fujita N., Hibi S., Ito E., Nakagawa M. Blood 1995; 86, 45a. (abstr. suppl. 1)
   PubMedGoogle Scholar
• Lowenberg B., Touw I. P. Hematopoietic growth factors and their receptors in acute leukemia. Blood 1993; 81: 281–292
   PubMed Web of Science ®Google Scholar
• Rambaldi A., Wakamiya N., Vellenga E., Horiguchi J., Warren M. K., Kuffe D., Griffin J. D. Expression of the macrophage colony stimulating factor and c-fms genes in human acute myeloblastic leukemia cells. J. Clin. Invest. 1988; 81: 1030–1035
   PubMed Web of Science ®Google Scholar
• Cozzolind F., Rubartelli A., Aldinucci D., Sitia R., Torcia M., Shaw A., Guglielmo R. Interleukin 1 as an autocrine growth factor for acute myeloid leukemia cells. Proc. Natl. Acad. Sci. USA 1989; 86, 2369–2373
   Web of Science ®Google Scholar
• Mitjavila M. T., Couedic J. P., Casadevall N., Navarro S., Vile-Val J. L., Dubart A., Vainchenker W. Autocrine stimulation by erythropoietin and autonomous growth of human erythroid leukemic cells in vitro. J. Clin. Invest. 1991; 88: 789–797
   PubMed Web of Science ®Google Scholar
• Chen Y. Z., Gu X. F., Caen J. P., Han Z. C. Interleukin-3 is an autocrine growth factor of human megakaryoblast, the DAMI, and Meg-O1 cells. Br. J. Haematol. 1994; 88: 481–487
   PubMed Web of Science ®Google Scholar
• Matsumura I., Kanakura Y., Ikeda H., Ishikawa J., Yoshida H., Horikawa Y., Nishiura T., Tahara T., Kato T., Miyazaki H., Matsuzawa Y. Coexpression of thrombopoietin and c-mpl genes in human acute myeloblastic leukemia cells. Leukemia 1996; 10: 91–94
   PubMed Web of Science ®Google Scholar
• Nagata Y., Nagahisa H., Aida Y., Okutomi K., Nagasawa T., Todokoro K. Thrombopoietin induces megakaryocyte differentiation in hematopoietic progenitor FDC-P2 cells. J. Biol. Chem. 1995; 270: 19673–19675
   PubMed Web of Science ®Google Scholar
• Vellenga E., Ostapovicz D., O'Rouke B., Griffin J. D. Effect of recombinant IL-3, GM-CSF, and G-CSF on proliferation of leukemic clonogenic cells in short-term and long-term cultures. Leukemia 1987; 1: 584–589
   PubMed Web of Science ®Google Scholar
• Salem M., Delwel R., Mahmoud L. A., Clark S., Elbasousy E. M., Lowenberg B. Maturation of human acute myeloid leukemia in vitro. Br. J. Haematol. 1989; 71: 363–370
   PubMed Web of Science ®Google Scholar